Randomized trial demonstrates improved disease-free survival with aspirin compared to placebo in colon cancer patients, suggesting potential benefits for treatment strategies.
Sensitivity analyses accounting for non-proportional hazards. Sensitivity analyses accounting for non-proportional hazards using restricted mean survival time. The separating curves over time indicate the benefit of aspirin over placebo on disease-free survival.
No takes yet. Share an insight, caveat, or question.
Güller et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: